TNF and irritable bowel syndrome: While anti-TNFs usually follow initial treatment in a step-up approach, in some patients with moderate-to-severe IBD and prognostic factors of unfavorable outcome (i.e., young age at diagnosis, perianal disease, penetrating disease in CD, and extensive disease) early anti-TNF and immunomodulator combination therapy may be beneficial (18–23).